David Lowrance
2020
In 2020, David Lowrance earned a total compensation of $808.5K as Chief Financial Officer & Secretary at Mast Therapeutics, a 16% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $161,596 |
---|---|
Option Awards | $245,296 |
Salary | $379,600 |
Other | $22,000 |
Total | $808,492 |
Lowrance received $379.6K in salary, accounting for 47% of the total pay in 2020.
Lowrance also received $161.6K in non-equity incentive plan, $245.3K in option awards and $22K in other compensation.
Rankings
In 2020, David Lowrance's compensation ranked 9,461st out of 13,090 executives tracked by ExecPay. In other words, Lowrance earned more than 27.7% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 9,461 | 28th |
Manufacturing | 4,052 | 28th |
Chemicals And Allied Products | 1,648 | 27th |
Drugs | 1,444 | 26th |
Pharmaceutical Preparations | 1,061 | 27th |
Lowrance's colleagues
We found two more compensation records of executives who worked with David Lowrance at Mast Therapeutics in 2020.